Femasys (FEMY) announces the receipt of the Medicines & Healthcare products Regulatory Agency approvals for the FemaSeed Intratubal Insemination product for female infertility treatment and two diagnostic devices, FemVue for tubal evaluation and FemCerv for cervical cancer detection.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.